Evidence map›Paper›PMID 20619006›Full record

ReviewBMC biology2010

Assessing the human immune system through blood transcriptomics.

Damien Chaussabel, Virginia Pascual, Jacques Banchereau

Registry-linked trialAbstract readReview
In one paragraph

Review in BMC biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01780857 (The Immune Signature of Palmoplantar Pustulosis), which is not on this map. Cited by 141 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
141citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01780857 completednot on this mapstarted 2013, after this paper: background citation

The Immune Signature of Palmoplantar Pustulosis

TypeobservationalSponsorBaylor Research InstituteRan2013 to 2014Enrolled30ConditionsPalmoplantar Pustulosis
3 · Its place in the literature

Who cites it

141 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. PULSAR: a Foundation Model for Multi-scale and Multi-cellular Biology.bioRxiv : the preprint server for biology · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

81 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Damien ChaussabelBaylor Institute for Immunology Research and Baylor Research Institute, 3434 Live Oak, Dallas, TX 75204, USA. damienc@baylorhealth.edu
Virginia Pascual
Jacques Banchereau

Funding

Targeting Dendritic Cells for Enhanced Musocal ImmunityU19AI057234 · NIAID · BAYLOR RESEARCH INSTITUTE · PI ZURAWSKI, GERARD · 2003 to 2013
$49.2M
Induction of melanoma immunity by dendritic cell subsetsP01CA084512 · NCI · ROCKEFELLER UNIVERSITY · PI BANCHEREAU, JACQUES F · 2000 to 2010
$12.1M
Blood Transcriptional Biomarker Profiles for Category B PathogensU01AI082110 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI LINSLEY, PETER S · 2009 to 2013
$6.3M
NCI NIH HHS P01 CA084512NIAID NIH HHS U01 AI082110NIAID NIH HHS U19 AI057234PHS HHS U19 AIO57234-02
6 · The paper itself

Abstract

Blood is the pipeline of the immune system. Assessing changes in transcript abundance in blood on a genome-wide scale affords a comprehensive view of the status of the immune system in health and disease. This review summarizes the work that has used this approach to identify therapeutic targets and biomarker signatures in the field of autoimmunity and infectious disease. Recent technological and methodological advances that will carry the blood transcriptome research field forward are also discussed.

Indexed as

Autoimmune DiseasesBiomarkersCommunicable DiseasesGene Expression ProfilingHumansImmune SystemBiomarkers

Identifiers

PMID20619006
PMCPMC2895587

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.